Palisade Bio Inc (PALI) concluded trading on Thursday at a closing price of $2.36, with 68.0 million shares of worth about $160.48 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -48.02% during that period and on December 12, 2024 the price saw a gain of about 68.57%. Currently the company’s common shares owned by public are about 1.43M shares, out of which, 1.40M shares are available for trading.
Stock saw a price change of 34.86% in past 5 days and over the past one month there was a price change of -0.84%. Year-to-date (YTD), PALI shares are showing a performance of -73.33% which decreased to -72.69% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.38 but also hit the highest price of $22.35 during that period. The average intraday trading volume for Palisade Bio Inc shares is 109.30K. The stock is currently trading 6.64% above its 20-day simple moving average (SMA20), while that difference is down -16.02% for SMA50 and it goes to -45.08% lower than SMA200.
Palisade Bio Inc (NASDAQ: PALI) currently have 1.43M outstanding shares and institutions hold larger chunk of about 4.36% of that.
The stock has a current market capitalization of $3.37M and its 3Y-monthly beta is at 1.39. It has posted earnings per share of -$15.04 in the same period. It has Quick Ratio of 3.28 while making debt-to-equity ratio of 0.05. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for PALI, volatility over the week remained 27.25% while standing at 16.07% over the month.
Stock’s fiscal year EPS is expected to rise by 54.26% while it is estimated to increase by 69.14% in next year.
